The present invention provides a prosthesis, for repairing hernias, for example, comprising a mesh and a member for reinforcing the mesh.
In humans the abdominal wall consists of fat and muscles interconnected by aponeuroses. A break in continuity may occur at the level of the aponeuroses, allowing part of the peritoneum to pass through and form a sac, known as a hernia, containing either fat or a portion of the intestine. Hernias or ventral ruptures (hernias occurring on a parietal surgical scar) are manifested by a protrusion on the surface of the skin and are called umbilical or inguinal hernias or ventral ruptures, for example, as a function of their location.
To repair a hernia, surgeons often fit a synthetic mesh prosthesis that replaces or reinforces the weakened anatomical tissue.
However, the efficacy of the prosthesis, and thus minimizing the risk of relapse, depend to a great degree on the proper fixing of the prosthesis. In particular, before being fixed, the prosthesis must be correctly spread over the abdominal wall that it is intended to reinforce. Prostheses of mesh type, i.e. based on an arrangement of threads forming a textile, are generally flexible, and to introduce them into the hernia they are often folded to reduce their volume. They therefore tend to form creases on the abdominal wall when they are introduced onto the implantation site. In this respect spreading them out is of primary importance but may prove difficult, in particular in the case of treating an umbilical hernia, which, being smaller than an inguinal hernia, offers little working space and little visibility for manipulation of the prosthesis by the surgeon.
In the case of umbilical hernias, for example, or when the aim of treatment is to repair trocart holes or preventive, the size of the defect to be treated is small, for example from 1 to 4 cm diameter, and open surgery may be envisaged without widening the defect. However, in this type of surgery, the surgeon has little working space and little visibility. It would thus be preferable to have a prosthesis that is easy to position, to spread out and to fix, if possible avoiding the necessity for sutures at the periphery of the prosthesis, which is complicated and laborious under such working conditions.
Failure to spread the prosthesis out perfectly against the abdominal wall leads to the risk of trapping the peritoneal sac and the risk of insertion of a soft organ between the prosthesis and the abdominal wall, which can lead to the risk of adhesions, pain and intestinal blockage and increase the possibility of relapse. It is therefore essential for the surgeon to be sure that no part of the prosthesis remains folded and that no viscera or any part of the intestines lie between the prosthesis and the abdominal wall. Moreover, incorrect positioning of the sutures or incorrect fixing of the prosthesis risks distortion of the prosthesis and the creation of tensions.
Thus in the case of an umbilical hernia in particular, having a small orifice for introducing the prosthesis, it would be beneficial to have a prosthesis adapted to occupy a small volume in a first configuration in order to facilitate its introduction into the abdominal cavity via said orifice and then to be deployed, spread out and pressed easily against the abdominal wall so that the surgeon is sure of the optimal positioning of the prosthesis and can moreover fix the prosthesis efficaciously without sutures at its periphery, and this, despite the little intrinsic visibility of small size hernias.
Various prostheses that may be folded up and then deployed are available.
The present invention concerns a prosthesis that is adapted to be folded up in order to reduce the volume that it occupies at the time of its introduction into a small incision and on the other hand to be spread out and fixed easily so that the surgeon is sure of the perfect spreading of the prosthesis and that it may be fixed efficaciously at a certain distance between the centre of the prosthesis and its periphery without sutures at the periphery of the prosthesis and this, despite the little intrinsic visibility of small size hernias.
The prosthesis of the invention is beneficial for treating hernias of the abdominal wall, in particular for treating umbilical hernias where the defect is small.
A first aspect of the present invention provides a prosthesis comprising:
The reinforcing member or frame may be rigid or have some flexibility. According to the present invention, the mesh and thus the prosthesis can be folded in two because of the presence of the two hinge points of the frame, regardless of the presence or not of intrinsic elastic properties of the frame.
In the context of the present application the term “mesh” refers to an arrangement of biocompatible threads, for example a knitted, woven or non-woven material, preferably of the openwork kind, i.e. having pores encouraging tissue recolonization. Such a mesh may be bioresorbable, partly bioresorbable or permanent. It is sufficiently flexible to be folded up at the time of its introduction into the abdominal cavity. The mesh may be produced from one layer of textile or from a plurality of layers of textiles. Such meshes are well known to the person skilled in the art. The mesh usable for the invention may be supplied in any shape (rectangular, square, circular, oval, etc.) and then cut to match the shape of the hernia defect. For example, the mesh may have the overall shape of a disc or an oval: in this case the frame also has a circular or oval shape and is preferably in the form of a ring. Alternatively, the mesh may have a globally square or rectangular shape: in this case the frame also has a square or rectangular shape. The frame is set back from the exterior peripheral edge of the mesh: thus, whilst adopting the shape of the contour of the mesh, the frame has an exterior perimeter smaller than that of the exterior peripheral edge of the mesh: in other words, the exterior peripheral edge of the mesh extends a certain distance beyond the frame. This distance may be greater than or equal to 1 mm, for example. In other words also, the frame and the exterior peripheral edge of the mesh are of similar geometric shape but the frame shows dimensions which are less than that of the exterior peripheral edge of the mesh.
As will become apparent from the following description, the shape of the frame and its location, set back slightly from the exterior peripheral edge of the mesh, enable the surgeon, when implanting the prosthesis, to fix it to the peritoneum efficaciously without requiring sutures at the periphery of the mesh: the surgeon is able to fix the prosthesis along the interior contour of the frame only, said interior contour defining a stitches fixing line: this avoids the surgeon having to apply stitches to the prosthesis at the exterior peripheral edge of the mesh, which is difficult to reach and hardly visible because of the small size of the incision. The interior contour of the frame of the prosthesis of the invention defines a fixing line, or stitching line, located approximately half way between the centre of the mesh and its exterior peripheral edge, along which the surgeon may locate the stitches when he fixes the prosthesis to the abdominal wall. Nevertheless, perfect spreading out of the prosthesis is assured by the presence of the frame which, by adopting the shape of the contour of the exterior peripheral edge, ensures deployment of the prosthesis and pressing thereof onto the abdominal wall.
In the context of the present application, by “anchor piece made of suturable material” is meant that the anchor piece is capable of being linked to, or passed through by, a thread-shaped element as defined in the present application, without being torn off when a user, such as a surgeon for example, exerts a moderate tension on said thread-shaped element, such as the necessary tension for orientating and/or positioning the prosthesis in the implantation site, as described hereinafter. Thus the anchor piece may be under the form of a textile, either knitted, woven or nonwoven, open worked or not; alternatively or in addition, the anchor piece may be under the form of a film or a sheet of material, as long as this textile, film and/or sheet of material is not torn off under the effect of the moderate tension as described above exerted on a thread-shaped element linked to, or passing through, said textile, film and/or sheet.
The anchor pieces may be made of bioresorbable material or not. The bioresorbable material may be chosen, for example, from polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), oxidized cellulose, polyglycol acid (PGA), copolymers of these materials and mixtures thereof.
As will be apparent from the following description, the anchor pieces are useful to the surgeon for facilitating the positioning of the prosthesis in the centre of the defect to be treated, and for attaching the prosthesis to the biological tissues. The anchor pieces also form the parts of the prosthesis by which said prosthesis is sutured to the abdominal wall.
The anchor pieces of the prosthesis of the invention are located on one single face of the mesh: as will be apparent from the following description, the anchor pieces are located on the face of the mesh intended to face the abdominal wall once the prosthesis is implanted: indeed, said anchor pieces are intended to be reached by the surgeon through the incision made for the implantation, in particular by means of thread-shaped elements, in view of assisting the surgeon to orientate and position the prosthesis as well as to raise the edges of the hernia defect for visualising the area to be stitched, when the prosthesis is put in place. The prosthesis of the invention thus comprises at least two anchor pieces located on either side of the folding line, preferably at two places which are symmetrical to each other with respect to this folding line: such a location of the anchor pieces enables the surgeon to expand the prosthesis optimally when it is put in place. According to the invention, the number of anchor pieces is not limited and the prosthesis may comprise 3 or 4 anchor pieces, even more. Each anchor piece shows a fixed part linked to the mesh of the prosthesis, and a free part, not attached to the mesh, and forming a type of shutter, flap or flying part. The fixed part of the anchor piece may be linked to the mesh by gluing, welding, sewing or by any biocompatible fixing means. In one embodiment, the anchor pieces are linked to the mesh via their fixed part by means of the reinforcing member.
The anchor pieces may show any geometrical shape. They may be identical or different.
In one embodiment, each anchor piece having a geometrical shape with at least one side having a length equal or greater than that of the other sides, each anchor piece is linked to the mesh by its longest side, along a direction perpendicular to the segment linking the centre of the mesh and the point of fixation of said piece in the plane of the mesh. In such an embodiment, each anchor piece being linked to the mesh by its longest side, the free part, or shutter or flap of each piece occupies only little space in the surroundings of the mesh: this enables maintaining a clear and non obstructed space around the hernia defect when the prosthesis is put in place and therefore allows the surgeon having a good visibility of the implantation site and not being impeded by the presence of useless extra elements. Such an embodiment also enables a more secure fixation of the anchor pieces to the mesh. Moreover, the positioning of the anchor pieces, i.e. along a direction perpendicular to the segment linking the centre of the mesh and the point of fixation of said piece in the plane of the mesh, allows the surgeon to position the prosthesis optimally by pulling on the thread-shaped elements linked to the anchor pieces in a centrifugal direction with respect to the hernia defect, as will be apparent in the following description.
In one embodiment, the suturable material is a textile and the anchor pieces are textile pieces. This textile may be identical to that of the mesh, or different. For example, the anchor pieces may be sewn to the mesh.
In the context of the present application, by “thread-shaped element”, is meant a flexible and elongated element, the length of which is much more greater than its thickness and its width, the contour of the cross section of which is globally circular: examples of thread-shaped elements of the invention may be a thread on its own, composite or not, or several threads, for example arranged together to make a braid, a tube, and combinations thereof. In embodiments, the thread-shaped elements are selected from threads, flexible tubes and combinations thereof.
In the prosthesis of the invention, the free part of each anchor piece is linked to at least one thread-shaped element. As will be apparent from the detailed description below, the thread-shaped element is intended to allow the surgeon to pull on the anchor piece linked thereto in order to expand, orientate and position the prosthesis when said prosthesis is put in place: preferably, the surgeon will pull simultaneously on the thread-shaped elements of the at least two anchor pieces which are present in order to counterbalance the prosthesis with respect to the defect to be treated. In addition, due to its structure, the thread-shaped element does not unnecessarily encumber the working area for the surgeon, said area being already naturally particularly limited regarding small size hernias.
In embodiments, the thread-shaped elements are flexible tubes: because of their hollow structure, necessitating a certain outer diameter, for example equal or greater than 3 mm, the tubes show a quite important outer surface capable of being in contact with the margins of the defect, this allowing decreasing dramatically the potential traumatic effect due to the contact of the tubes with the margins of the defect. The flexibility of the tubes allows their easy handling with no risk of damaging the tissues. Preferably, the tubes are flexible and semi-rigid. As will appear from the following description, such a semi-rigidity of the tubes allows maintaining the anchor pieces to which they are linked under slight tension, without having to apply any particular tension on these tubes. The flexible tubes may be in plastic material, silicone, or a combination of these materials.
In one embodiment of the invention, the mesh of the prosthesis of the invention is a knitted fabric: because of the stitches that form it, a knitted fabric makes it possible to obtain openwork faces encouraging cellular recolonization after implantation. The knitted fabric may be a two-dimensional knitted fabric or a three-dimensional knitted fabric.
In the context of the present application, the expression “two-dimensional knitted fabric” means a knitted fabric having two opposite faces linked together by stitches but having no spacers imparting a certain thickness to it: such a knitted fabric may be obtained, for example, by knitting threads on a warp or Raschel knitting machine using two guide bars. Examples of two-dimensional knitted fabrics suitable for the present invention are given in the document WO2009/071998.
In the present application, the expression “three-dimensional knitted fabric” means a knitted fabric having two opposite faces linked together by spacers imparting a significant thickness to the knitted fabric, said spacers consisting of connecting threads additional to the threads forming the two faces of the knitted fabric. Such a knitted fabric may be obtained, for example, using a double-bed Raschel knitting machine or warp knitting machine with a plurality of guide bars. Examples of knitting three-dimensional knitted fabrics suitable for the present invention are given in the documents WO99/05990, WO2009/031035, WO2009/071998.
In one embodiment, said frame is set back from the exterior peripheral edge of the mesh and is of serpentine shape, forming undulations. For example, said frame is in the form of a flat ribbon forming undulations substantially in the plane of said mesh. As will become apparent from the description given hereinafter, this configuration of the frame makes it possible, when fixing the prosthesis to the biological tissue, to execute a suture in the prosthesis at a given location without deforming the prosthesis as a whole during this operation; deformation of the prosthesis caused by the suture at the given location is smoothed out by the undulating frame. Thus the frame and therefore the rest of the prosthesis remain correctly positioned, and in particular remain pressed against the abdominal wall, during the fixing of the prosthesis.
In one embodiment, said reinforcing member is produced in bioresorbable material. Thus the reinforcing member fulfils its role of stiffening the prosthesis during positioning and implantation of the prosthesis and is then degraded progressively once the mesh is recolonized by the surrounding cells.
The bioresorbable material may be chosen, for example, from polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), oxidized cellulose, polyglycol acid (PGA), copolymers of these materials and mixtures thereof.
Alternatively, the reinforcing member is produced in a non-bioresorbable material chosen from polypropylene, a polyester such as polyethylene terephthalate, polyamide, silicone, polyetheretherketone (PEEK), polyaryletheretherketone (PAEK) and mixtures thereof.
In another embodiment, said reinforcing member is produced from a combination of bioresorbable material and non-bioresorbable material.
In one embodiment of the invention said mesh has the shape of a disc, said frame being substantially in the form of a circular ring. In such an embodiment, said anchor pieces may be fixed to two diametrically opposed places of an inner perimeter of said ring, said two places being spaced by 90° from each of said two hinge points. Such an embodiment enables an optimal deployment of the prosthesis by pulling in opposite directions on the respective thread-shaped elements of the two anchor pieces after the folded prosthesis has been introduced in the implantation site.
Alternatively, the prosthesis comprises four said anchor pieces distributed substantially regularly along an inner perimeter of said ring so that two anchor pieces are located on one side of the folding line and the other two anchor pieces are located on the other side of said folding line. In such an embodiment, for example, a single thread-shaped element links together the free parts of two anchor pieces located on the same side of the folding line. The total number of thread-shaped elements thus remains low and the surgeon is not impeded by the presence of extra thread-shaped elements. Moreover, the deployment and orientation step of the prosthesis is rendered easier: indeed, each thread-shaped element, because it links together the free parts of two anchor pieces located on the same side of the folding line, forms a sort of loop that the surgeon may very easily grasp and handle, in particular in view of exerting a tension on this loop: in addition, such a tension enables pulling on two anchor pieces simultaneously, at two different places of the mesh, thereby allowing optimised deployment and spreading out of the mesh and of the prosthesis.
Alternatively, a single thread-shaped element may link together the free parts of two adjacent anchor pieces located on each side of the folding line.
In embodiments, the anchor pieces have a colour different than that of the mesh. Alternatively or in addition, the thread-shaped elements have a colour different than that of the mesh and than that of the anchor pieces. Thanks to the present invention, the surgeon works in a relative non obstructed implantation site where he can see the area of the prosthesis to be attached to the abdominal wall, this area being located more or less in the middle between the centre of the mesh and the edge of the mesh: such embodiments of the prosthesis of the invention allow the surgeon to easily and rapidly make the necessary stitches by enabling him, thanks to the different colours, to quickly identify whether he handles the mesh, the anchor pieces or the thread-shaped elements.
In one embodiment of the invention, the face of the mesh opposite that including said anchor pieces is covered with a non-adherent coating.
Such a coating makes it possible in particular to avoid the formation of unwanted severe post-operative fibrous adhesions.
In the context of the present application the expression “non-adherent” refers to a non-porous, smooth, biocompatible coating or material offering no space for cellular recolonization and preferably encouraging the birth of a peritoneum.
In embodiments, where the prosthesis comprises four said anchor pieces distributed substantially regularly along an inner perimeter of said ring so that two anchor pieces are located on one side of the folding line and the other two anchor pieces are located on the other side of said folding line, all four anchor pieces are under the form of isosceles triangles of textile, each triangle being fixed to said mesh via its base, all four triangles showing identical elongation and tensile strength properties in the centripetal direction.
For example, each isosceles triangle is fixed to the mesh via its base by means of the ring, the thread-shaped element being attached to the vertex angle of the isosceles triangle. Because of the four isosceles triangles of textile having the same mechanical properties in the centripetal direction, when the surgeon pulls on the thread-shaped elements at the time he puts the prosthesis in place and fixes it to the abdominal wall, all anchor pieces react similarly and the traction exerted by the surgeon on the whole prosthesis via the thread-shaped elements is regularly distributed. The prosthesis is therefore properly positioned. In addition, in embodiments where the four isosceles triangles of textile have a colour different from that of the mesh, the surgeon readily identifies the stitching line as defined above and the step of fixing the prosthesis to the abdominal wall is facilitated. As will appear from the description below, the method of manufacturing a prosthesis with four anchor pieces under the form of four isosceles triangle of textile having identical mechanical properties is simple and easy.
The present invention will emerge more clearly from the description given hereinafter and from the appended drawings, in which:
The mesh 1 is made from a knitted, woven or non-woven arrangement of biocompatible threads. It may be bioresorbable, partly bioresorbable or permanent. The mesh is generally openwork, incorporating pores for better tissue integration. This mesh 1 is sufficiently flexible to be folded when the prosthesis is introduced into the abdominal cavity 109 via the incision 110. However, the mesh is generally a textile having no elasticity enabling it to return to a spread out configuration of its own accord after it has been folded up. The mesh 1 may be produced from a textile layer or a plurality of textile layers. The textile may be a two-dimensional or three-dimensional knitted fabric. Such meshes are well known to the person skilled in the art and are not described in more detail here. The mesh may be supplied in the form of a strip that is cut to the dimensions of the defect to be treated. In the example represented, the mesh 1 has the shape of a disc adapted to the shape of the incision 110 at the hernia defect 100 and delimited by an exterior peripheral edge 1a. In other embodiments, the mesh may be of oval shape. Alternatively, the mesh may be of rectangular or square shape.
The frame 2 thus consists of two parts, namely two semicircles 2a and 2b, connected together by two hinge points (3a, 3b). As seen in
As seen in
The undulations 4 of the frame 2 may be regular or not. In particular, in the example shown, the frame 2 is in the form of a flat ribbon of material forming undulations 4 in the plane of the frame 2, which is substantially the plane of the prosthesis. As will become apparent in the remainder of the description, such a shape imparts to the frame 2 great flexibility in the plane of the frame 2 and thus in the plane of the prosthesis: it is thus possible to suture part of the prosthesis at a given place, without rocking or deforming the prosthesis as a whole: the deformation created at the location of the suture is smoothed out by the undulations 4 of the frame 2 over the whole of the periphery of the prosthesis. In addition, the frame 2 shows a rigidity along its section, so that it neither deforms radially in the outward nor in the inward directions.
Materials suitable for producing the reinforcing member of the prosthesis of the invention may be any biocompatible materials having some rigidity so as to respond to the expectations disclosed above.
The frame 2 can thus be produced in any biocompatible material, bioresorbable or not. In a preferred embodiment, it is made in bioresorbable material. In the present application, the term “bioresorbable” refers to the characteristic whereby a material is absorbed by biological tissues and disappears in vivo after a given period, which may vary from one day to several months, for example, depending on the chemical nature of the material.
Bioresorbable materials suitable for the fabrication of the reinforcing member of the prosthesis of the present invention include polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), oxidized cellulose, polyglycolic acid (PGA), copolymers of these materials and mixtures thereof. Bioresorbable materials suitable for the fabrication of the reinforcing member of the prosthesis of the invention include polyester (glycolid, dioxanone, trimethylene carbonate) available from the company Covidien under the trade name “BIOSYN®” and polyester (glycolid, caprolactone, trimethylene carbonate, lactid) available commercially from the company Covidien under the trade name “CAPROSYN®”.
Non-bioresorbable materials suitable for the fabrication of the reinforcing member of the prosthesis of the present invention include polypropylene, polyesters such as polyethylene terephthalate, polyamide, silicone, polyetheretherketone (PEEK), polyaryletheretherketone (PAEK) and mixtures thereof.
Each part of the reinforcing member of the prosthesis of the invention may be made in one piece, for example, by injection moulding one or more biocompatible thermoplastic or thermosetting materials. The hinge points (3a, 3b) of the frame 2 may be produced in the same material as the rest of the frame: these hinge points (3a, 3b) take the form for example of very thin bridges of material in order to enable folding of the frame 2 without causing separation of the two parts joined together by these bridges.
With reference to
In embodiments, such as those shown on
On
On
As will be apparent from the following detailed description, the thread-shaped element is intended to allow the surgeon to pull on the anchor piece linked thereto in order to expand, orientate and position the prosthesis when said prosthesis is put in place: preferably, the surgeon will pull simultaneously on the thread-shaped elements of the at least two anchor pieces which are present in order to centre and counterbalance the prosthesis with respect to the defect to be treated.
With reference to
With reference to
The tube 7 is flexible and, because of its hollow structure, necessitating a certain outer diameter, for example equal to or greater than 3 mm, it shows a quite important outer surface capable of being in contact with the margins of the defect, this allowing decreasing dramatically the potential traumatic effect due to the contact of the tube 7 with the margins of the defect. The flexible tube 7 may be in plastic material, silicone, or in a combination of these materials.
The anchor pieces 5 of the prosthesis of the invention are made of a suturable material: in the context of the present application, it is hereby meant that the anchor piece 5 is capable of being linked to, or passed through by, a thread-shaped element, such as a thread 6 or a tube 7, without being torn off when a user, such as a surgeon for example, exerts a moderate tension on said thread-shaped element, such as the necessary tension for orientating and/or positioning the prosthesis in the implantation site, as described hereinafter. The anchor pieces 5 may be made of any biocompatible suturable material giving them the necessary flexibility for being grasped by the surgeon when the prosthesis is put in place, as will be described hereinafter.
The anchor piece 5 may be under the form of a textile, either knitted, woven or nonwoven, open worked or not; alternatively or in addition, the anchor piece may be under the form of a film or a sheet of material, as long as this textile, film and/or sheet of material is not torn off under the effect of the moderate tension as described above exerted on a thread-shaped element linked to, or passing through, said textile, film and/or sheet.
As will be apparent from the following description, the anchor pieces are useful to the surgeon for facilitating the positioning of the prosthesis in the centre of the defect to be treated, and for attaching the prosthesis to the biological tissues. The anchor pieces also form the parts of the prosthesis by which said prosthesis is sutured to the abdominal wall.
With reference to
As is apparent from this
The anchor pieces 5 being fixed to the mesh by their longest side, they do not impede the surgeon at the time of the prosthesis is implanted. On
With reference to
In these embodiments, the four anchor pieces 5 are arranged regularly along an inner perimeter of the ring formed by the frame 2 so that two anchor pieces 5 are located on one side of the folding line M and the two other anchor pieces are located on the other side of the folding line M: the four anchor pieces therefore counterbalance one another. Each anchor piece 5 is fixed to the mesh 1 by its fixed part 5a, the free parts 5b being left flying and forming flaps. For example, each fixed part 5a is attached to the mesh 1 by a seaming 8. Moreover, a single thread-shaped element (6, 7) links together the free parts 5b of two anchor pieces 5 located on the same side of the folding line M.
With reference to
With reference to
With reference to
The presence of the four anchor pieces 5, regularly distributed as described above in
In one embodiment of the prosthesis 200 not shown, the reinforcing member, namely the frame 2, is welded directly to the mesh 1 and to the fixed parts 5a of anchor pieces 5. Thus the frame 2 is fastened both to the mesh 1 and to the anchor pieces 5.
In the
The non-adherent coating or material is chosen from bioresorbable materials, non-bioresorbable materials and mixtures thereof. The non-bioresorbable non-adherent materials may be chosen from polytetrafluoroethylene, polyethylene glycol, polysiloxane, polyurethane, and mixtures thereof.
Said non-adherent coating or material is preferably bioresorbable: bioresorbable materials suitable for said non-adherent coating may be chosen from collagen, oxidized cellulose, polyacrylate, trimethylene carbonate, caprolactone, dioxanone, glycolic acid, lactic acid, glycolide, lactide, polysaccaride, for example chitosan, polyglucuronic acid, hyaluronic acid, dextran and mixtures thereof.
The non-adherent coating makes it possible to protect the mesh 1 of the prosthesis 200 at least during the initial scar formation phase, i.e. the mesh 1 is not exposed to inflammatory cells, such as granulocytes, monocytes, macrophages or the giant multinucleated cells generally activated by surgery. At least during the initial scar formation phase, the duration of which may vary from about 5 days to about 10 days, only the non-adherent coating is accessible to the various factors such as proteins, enzymes, cytokines or inflammatory cells.
If the non-adherent coating consists of non-resorbable materials, it thus protects the mesh 1 before and after implantation and throughout the duration of implantation of the prosthesis 200.
Moreover, thanks to the non-adherent coating, surrounding fragile tissues, such as the hollow viscera, for example, are protected, in particular from unwanted severe post-operative fibrous adhesion.
If the non-adherent material includes a bioresorbable material, it is preferable to choose a bioresorbable material that is not resorbed in less than a few days in order for the non-adherent coating to be able to fulfil its function of protecting the intestine and hollow organs during the days following surgery until cellular rehabilitation of the prosthesis takes over protecting these fragile organs.
Because of its two-part reinforcing member, namely the frame 2 consisting of the two semicircles 2a and 2b in the example shown, connected together by hinge points 3a, 3b, the prosthesis 200 of the invention may adopt a folded configuration after the surgeon folds it along the folding line M. Thus to implant the prosthesis 200 the surgeon folds it in two so that it occupies a smaller volume, which facilitates introduction of the prosthesis into the hernia defect 100 (see
The mesh 1 and the non-adherent coating 201 are sufficiently flexible to follow successive deformations of the prosthesis 200 as the latter is introduced to the implantation site.
As will appear from the description below, the four anchor pieces 215 of prosthesis 210 are arranged symmetrically along the interior contour of the ring formed by the frame 2, and they all have the same mechanical properties.
The manufacturing process of such embodiments will now be described with reference to
With reference to
Preferably, the textile 20 has a colour different from that of the mesh 1.
In order to proceed with the manufacturing of the four anchor pieces 215, a cutting 21 having the shape of a cross with two perpendicular branches (22, 23) is completed on textile 20, with one branch 22 of the cross parallel to the warp direction Wa and the other branch 23 of the cross parallel to the weft direction We, as shown on
In a further step, the textile 20 is laid upon a piece of mesh 1, for example of similar square shape and dimensions as the textile 20, and the frame 2 of
As shown on
Once the frame 2 is welded, the disc-shape prosthesis 210 may be manufactured by cutting the mesh 1 and textile 20 in excess beyond the outer peripheral border of the frame 2, as shown on
As mentioned above, a thread-shaped element (not shown) may then be attached to the free vertex angle 24b of each triangle 24 by any fixation means such as those described above at
Because of the specific cross-shaped cutting 21, with one branch parallel to the warp direction Wa and the other branch parallel to the weft direction We, all four isosceles triangles 24 of textile 20 are identical and they all show the same mechanical properties, such as elongation properties and tensile strength properties, each in the direction of its altitude 24c corresponding to the centripetal direction of the disc-shape prosthesis 210, regardless from the fact that the initial elongation and tensile strength properties of the textile 20 in its warp direction Wa were identical or not to its initial elongation and tensile strength properties in the weft direction We.
Indeed, because of the location of the cutting 21 with respect to the frame 2 during the welding step, the altitude direction or centripetal direction for each triangle 24 forms an angle of 45° with respect to both warp and weft directions of the initial textile 20.
As a consequence, all four anchor pieces 215 show the same mechanical properties, in particular elongation properties and tensile strength properties, in the direction corresponding to the direction of the altitude 24c of each triangle 24, in other words in the direction corresponding to the direction of the traction exerted by the surgeon when he pulls on the thread-shaped element (not shown) in order to put the prosthesis in place and to fix it to the abdominal wall.
As a consequence, when the surgeon pulls on the thread-shaped element at the time he puts the prosthesis 210 in place and fixes it to the abdominal wall, all anchor pieces 215 react similarly and the traction exerted by the surgeon on the whole prosthesis 210 via the four anchor pieces is equally distributed. The prosthesis 210 is therefore properly positioned. In addition, because the four isosceles triangles 24 of textile 20 have a colour different from that of the mesh 1, the surgeon readily identifies the stitching line as defined above. The step of fixing the prosthesis 210 to the abdominal wall is therefore facilitated.
The method of manufacturing the prosthesis 210 described above is very simple and allows starting from a single piece of textile 20 for manufacturing the four anchor pieces 215.
Alternatively, the prosthesis 210 may be manufactured by preparing initially four separate triangles 24 of textile 20 and welding each triangle 24 to the mesh 1 via the frame 2, or alternatively by preparing two pieces of semi-discs of textile 20, completing a perpendicular cutting on each semi-disc and welding the two cut semi-discs to the mesh via the frame 2.
Like the prosthesis 200 of
The fitting of a prosthesis of the invention, for example the prosthesis 200 from
After making the incision 110 described with reference to
Once the prosthesis 200 is in the abdominal cavity 109, the surgeon releases the pressure on it. It is the surgeon who manually deploys the prosthesis 200 in a perfectly tensioned and spread out configuration. Thus, the prosthesis 200 being able to adopt only two positions, namely folded in two or spread out, the surgeon is certain that the prosthesis is perfectly spread out from the moment of unfolding the prosthesis 200.
In the next step, as shown in
Once the prosthesis 200 is correctly positioned relative to the hernia defect, the surgeon raises a part of the edge of the hernia with the help of the tubes 7 and thus uncovers a central area 12 in the vicinity of the prosthesis 200, delimited overall by the anchor pieces 5, which area the surgeon may easily view and in which the surgeon is able to work easily.
In an embodiment, the tubes 7 are flexible and semi-rigid. Such a semi-rigidity of the tubes 7 allows maintaining the anchor pieces 5 to which they are linked under slight tension, without having to apply any particular tension on these tubes: as such, once the surgeon has raised the edges of the hernia defect by pulling on the flexible and semi-rigid tubes 7 in order to uncover a working area, he can release the tension on the tubes 7: the anchor pieces 5 remain under slight tension and maintain the edges of the defect in a raised position.
In embodiments, the anchor pieces 5 are of a colour different than that of the mesh 1: indeed, because the fixation area of the prosthesis 200 to the abdominal wall (101, 104) is located more or less in the middle between the centre 1b of the mesh 1 and the edge of the mesh, the surgeon can differentiate the different colours between the various elements forming the prosthesis 200 and thus easily identify the anchor pieces 5 he has to suture: such a thing is not possible with the prosthesis of the prior art intended to be fixed to the abdominal wall at their periphery. In particular, the colour difference between the anchor pieces 5 and the mesh 1 defines a line, said line pointing out to the surgeon where to complete the stitches for fixing the prosthesis 200 to the abdominal wall. This fixing line, or stitching line, globally corresponds to the interior contour of the frame 2. Also, for the same reasons, the thread-shaped elements, like the tubes 7, may be of a colour different from that of the mesh and from that of the anchor pieces 5.
In a following step, as shown in
As may be seen in
Once the surgeon has executed the necessary stitches 11 over all the anchor pieces 5, he cuts each thread-shaped element, here each tube 7, at its junction with the free part 5b of the anchor piece 5 in order to retain at the implantation site only the anchor pieces 5, as shown in
The surgeon then has only to close the incision 110 in the conventional way for small size hernias, i.e. by stitches.
The prosthesis of the invention is particularly simple to install, the surgeon being easily able to uncover a comfortable and non obstructed working area, despite the restricted size of the implantation site. The fitting of the prosthesis of the invention is also particularly reliable, all risk of trapping the viscera being avoided. A prosthesis of the invention is particularly suitable for treating umbilical hernias where the abdominal incision made is of small size. The prosthesis of the invention is adapted to adopt a configuration in which it occupies a particularly small volume facilitating its introduction into the abdominal cavity via a small incision without necessitating the use of any dedicated ancillary device. Thanks to its particular structure, the prosthesis of the invention may be spread out and pressed onto the abdominal wall efficaciously, also without necessitating the use of a dedicated tool to assist spreading it and it may be attached securely to the abdominal wall at an area located more or less in the middle between the centre of the prosthesis and its periphery: the surgeon is therefore prevented from having to make stitches at far distance places, such as the periphery of the prosthesis, that he cannot see. The prosthesis of the invention thus makes it possible to treat a hernia, in particular an umbilical hernia, efficaciously, simply and rapidly, minimizing the risk of relapse.
Number | Date | Country | Kind |
---|---|---|---|
11/56425 | Jul 2011 | FR | national |
This application is a divisional application of U.S. patent application Ser. No. 16/927,735 filed Jul. 13, 2020, which is a continuation of U.S. patent application Ser. No. 15/963,523 filed Apr. 26, 2018, now U.S. Pat. No. 10,709,538, which is a continuation application of U.S. patent application Ser. No. 14/232,378 filed Mar. 24, 2014, now U.S. Pat. No. 9,980,802, which is a National Stage Application of PCT/EP2012062672 filed Jun. 29, 2012, which claims benefit of and priority to French Patent Application No. 11/56425 filed Jul. 13, 2011, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
1187158 | Mcginley | Jun 1916 | A |
2153889 | Hames | Apr 1939 | A |
3054406 | Usher | Sep 1962 | A |
3118294 | Van Laethem | Jan 1964 | A |
3124136 | Usher | Mar 1964 | A |
3272204 | Artandi et al. | Sep 1966 | A |
3276448 | Kronenthal | Oct 1966 | A |
3320649 | Naimer | May 1967 | A |
3364200 | Ashton et al. | Jan 1968 | A |
3570482 | Shigeru et al. | Mar 1971 | A |
3718725 | Hamano | Feb 1973 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4060081 | Yannas et al. | Nov 1977 | A |
4173131 | Melton et al. | Nov 1979 | A |
4193137 | Heck | Mar 1980 | A |
4248064 | Odham | Feb 1981 | A |
4294241 | Miyata | Oct 1981 | A |
4307717 | Hymes et al. | Dec 1981 | A |
4338800 | Matsuda | Jul 1982 | A |
4476697 | Schafer et al. | Oct 1984 | A |
4487865 | Balazs et al. | Dec 1984 | A |
4500676 | Balazs et al. | Feb 1985 | A |
4511653 | Play et al. | Apr 1985 | A |
4527404 | Nakagaki et al. | Jul 1985 | A |
4591501 | Cioca | May 1986 | A |
4597762 | Walter et al. | Jul 1986 | A |
4603695 | Ikada et al. | Aug 1986 | A |
4631932 | Sommers | Dec 1986 | A |
4670014 | Huc et al. | Jun 1987 | A |
4709562 | Matsuda | Dec 1987 | A |
4748078 | Doi et al. | May 1988 | A |
4759354 | Quarfoot | Jul 1988 | A |
4769038 | Bendavid et al. | Sep 1988 | A |
4796603 | Dahlke et al. | Jan 1989 | A |
4813942 | Alvarez | Mar 1989 | A |
4841962 | Berg et al. | Jun 1989 | A |
4854316 | Davis | Aug 1989 | A |
4925294 | Geshwind et al. | May 1990 | A |
4931546 | Tardy et al. | Jun 1990 | A |
4942875 | Hlavacek et al. | Jul 1990 | A |
4948540 | Nigam | Aug 1990 | A |
4950483 | Ksander et al. | Aug 1990 | A |
4970298 | Silver et al. | Nov 1990 | A |
4976737 | Leake | Dec 1990 | A |
5002551 | Linsky et al. | Mar 1991 | A |
5015584 | Brysk | May 1991 | A |
5116357 | Eberbach | May 1992 | A |
5147374 | Fernandez | Sep 1992 | A |
5162430 | Rhee et al. | Nov 1992 | A |
5171273 | Silver et al. | Dec 1992 | A |
5176692 | Wilk et al. | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5195542 | Gazielly et al. | Mar 1993 | A |
5196185 | Silver et al. | Mar 1993 | A |
5201745 | Tayot et al. | Apr 1993 | A |
5201764 | Kelman et al. | Apr 1993 | A |
5206028 | Li | Apr 1993 | A |
5217493 | Raad et al. | Jun 1993 | A |
5254133 | Seid | Oct 1993 | A |
5256418 | Kemp et al. | Oct 1993 | A |
5258000 | Gianturco | Nov 1993 | A |
5263983 | Yoshizato et al. | Nov 1993 | A |
5304595 | Rhee et al. | Apr 1994 | A |
5306500 | Rhee et al. | Apr 1994 | A |
5324775 | Rhee et al. | Jun 1994 | A |
5328955 | Rhee et al. | Jul 1994 | A |
5334527 | Brysk | Aug 1994 | A |
5339657 | Mcmurray | Aug 1994 | A |
5350583 | Yoshizato et al. | Sep 1994 | A |
5356432 | Rutkow et al. | Oct 1994 | A |
5368549 | Mcvicker | Nov 1994 | A |
5368602 | Torre | Nov 1994 | A |
5370650 | Jonathan et al. | Dec 1994 | A |
5376375 | Rhee et al. | Dec 1994 | A |
5376376 | Li | Dec 1994 | A |
5397331 | Himpens et al. | Mar 1995 | A |
5399361 | Song et al. | Mar 1995 | A |
5413791 | Rhee et al. | May 1995 | A |
5425740 | Hutchinson, Jr. | Jun 1995 | A |
5428022 | Palefsky et al. | Jun 1995 | A |
5433996 | Kranzler et al. | Jul 1995 | A |
5441491 | Verschoor et al. | Aug 1995 | A |
5441508 | Gazielly et al. | Aug 1995 | A |
5456693 | Conston et al. | Oct 1995 | A |
5456711 | Hudson | Oct 1995 | A |
5466462 | Rosenthal et al. | Nov 1995 | A |
5480644 | Freed | Jan 1996 | A |
5487895 | Dapper et al. | Jan 1996 | A |
5490984 | Freed | Feb 1996 | A |
5512291 | Li | Apr 1996 | A |
5512301 | Song et al. | Apr 1996 | A |
5514181 | Light et al. | May 1996 | A |
5522840 | Krajicek | Jun 1996 | A |
5523348 | Rhee et al. | Jun 1996 | A |
5536656 | Kemp et al. | Jul 1996 | A |
5543441 | Rhee et al. | Aug 1996 | A |
5565210 | Rosenthal et al. | Oct 1996 | A |
5567806 | Abdul-Malak et al. | Oct 1996 | A |
5569273 | Titone et al. | Oct 1996 | A |
RE35399 | Eisenberg | Dec 1996 | E |
5593441 | Lichtenstein et al. | Jan 1997 | A |
5595621 | Light et al. | Jan 1997 | A |
5601571 | Moss | Feb 1997 | A |
5607474 | Athanasiou et al. | Mar 1997 | A |
5607590 | Shimizu | Mar 1997 | A |
5614587 | Rhee et al. | Mar 1997 | A |
5618551 | Tardy et al. | Apr 1997 | A |
5634931 | Kugel | Jun 1997 | A |
5639796 | Lee | Jun 1997 | A |
5665391 | Lea | Sep 1997 | A |
5667839 | Berg | Sep 1997 | A |
5676967 | Williams et al. | Oct 1997 | A |
5681568 | Goldin et al. | Oct 1997 | A |
5686090 | Schilder et al. | Nov 1997 | A |
5686115 | Vournakis et al. | Nov 1997 | A |
5690675 | Sawyer et al. | Nov 1997 | A |
5695525 | Mulhauser et al. | Dec 1997 | A |
5697978 | Sgro | Dec 1997 | A |
5700476 | Rosenthal et al. | Dec 1997 | A |
5700477 | Rosenthal et al. | Dec 1997 | A |
5702416 | Kieturakis et al. | Dec 1997 | A |
5709934 | Bell et al. | Jan 1998 | A |
5711960 | Shikinami | Jan 1998 | A |
5716409 | Debbas | Feb 1998 | A |
5720981 | Eisinger | Feb 1998 | A |
5732572 | Litton | Mar 1998 | A |
5743917 | Saxon | Apr 1998 | A |
5749895 | Sawyer et al. | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5766246 | Mulhauser et al. | Jun 1998 | A |
5766631 | Arnold | Jun 1998 | A |
5769864 | Kugel | Jun 1998 | A |
5771716 | Schlussel | Jun 1998 | A |
5785983 | Furlan et al. | Jul 1998 | A |
5800541 | Rhee et al. | Sep 1998 | A |
5814328 | Gunasekaran | Sep 1998 | A |
5833705 | Ken et al. | Nov 1998 | A |
5840011 | Landgrebe et al. | Nov 1998 | A |
5861034 | Taira et al. | Jan 1999 | A |
5863984 | Doillon et al. | Jan 1999 | A |
5869080 | Mcgregor et al. | Feb 1999 | A |
5871767 | Dionne et al. | Feb 1999 | A |
5876444 | Lai | Mar 1999 | A |
5891558 | Bell et al. | Apr 1999 | A |
5899909 | Claren et al. | May 1999 | A |
5906937 | Sugiyama et al. | May 1999 | A |
5910149 | Kuzmak | Jun 1999 | A |
5911731 | Pham et al. | Jun 1999 | A |
5916225 | Kugel | Jun 1999 | A |
5919232 | Chaffringeon et al. | Jul 1999 | A |
5919233 | Knopf et al. | Jul 1999 | A |
5922026 | Chin | Jul 1999 | A |
5931165 | Reich et al. | Aug 1999 | A |
5942278 | Hagedorn et al. | Aug 1999 | A |
5962136 | Dewez et al. | Oct 1999 | A |
5972022 | Huxel | Oct 1999 | A |
RE36370 | Li | Nov 1999 | E |
5993844 | Abraham et al. | Nov 1999 | A |
5994325 | Roufa et al. | Nov 1999 | A |
5997895 | Narotam et al. | Dec 1999 | A |
6001895 | Harvey et al. | Dec 1999 | A |
6008292 | Lee et al. | Dec 1999 | A |
6015844 | Harvey et al. | Jan 2000 | A |
6039686 | Robert | Mar 2000 | A |
6042534 | Gellman et al. | Mar 2000 | A |
6042592 | Schmitt | Mar 2000 | A |
6043089 | Sugiyama et al. | Mar 2000 | A |
6051425 | Morota et al. | Apr 2000 | A |
6056688 | Benderev et al. | May 2000 | A |
6056970 | Greenawalt et al. | May 2000 | A |
6057148 | Sugiyama et al. | May 2000 | A |
6063396 | Kelleher | May 2000 | A |
6066776 | Goodwin et al. | May 2000 | A |
6066777 | Benchetrit | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6077281 | Das | Jun 2000 | A |
6080194 | Pachence et al. | Jun 2000 | A |
6083522 | Chu et al. | Jul 2000 | A |
6090116 | D Aversa et al. | Jul 2000 | A |
6113623 | Sgro | Sep 2000 | A |
6120539 | Eldridge et al. | Sep 2000 | A |
6132765 | Dicosmo et al. | Oct 2000 | A |
6143037 | Goldstein et al. | Nov 2000 | A |
6153292 | Bell et al. | Nov 2000 | A |
6162962 | Hinsch et al. | Dec 2000 | A |
6165488 | Tardy et al. | Dec 2000 | A |
6171318 | Kugel et al. | Jan 2001 | B1 |
6174320 | Kugel et al. | Jan 2001 | B1 |
6176863 | Kugel et al. | Jan 2001 | B1 |
6179872 | Bell et al. | Jan 2001 | B1 |
6180848 | Flament et al. | Jan 2001 | B1 |
6197325 | Macphee et al. | Mar 2001 | B1 |
6197934 | Devore et al. | Mar 2001 | B1 |
6197935 | Doillon et al. | Mar 2001 | B1 |
6210439 | Firmin et al. | Apr 2001 | B1 |
6214020 | Mulhauser et al. | Apr 2001 | B1 |
6221109 | Geistlich et al. | Apr 2001 | B1 |
6224616 | Kugel | May 2001 | B1 |
6241768 | Agarwal et al. | Jun 2001 | B1 |
6258124 | Darois et al. | Jul 2001 | B1 |
6262332 | Ketharanathan | Jul 2001 | B1 |
6264702 | Ory et al. | Jul 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6270530 | Eldridge et al. | Aug 2001 | B1 |
6277397 | Shimizu | Aug 2001 | B1 |
6280453 | Kugel et al. | Aug 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6290708 | Kugel et al. | Sep 2001 | B1 |
6306079 | Trabucco | Oct 2001 | B1 |
6306424 | Vyakamam et al. | Oct 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6319264 | Tormala et al. | Nov 2001 | B1 |
6328686 | Robert | Dec 2001 | B1 |
6334872 | Termin et al. | Jan 2002 | B1 |
6371975 | Cruise et al. | Apr 2002 | B2 |
6383201 | Dong | May 2002 | B1 |
6391060 | Ory et al. | May 2002 | B1 |
6391333 | Li et al. | May 2002 | B1 |
6391939 | Tayot et al. | May 2002 | B2 |
6408656 | Ory et al. | Jun 2002 | B1 |
6410044 | Chudzik et al. | Jun 2002 | B1 |
6413742 | Olsen et al. | Jul 2002 | B1 |
6425924 | Rousseau | Jul 2002 | B1 |
6428978 | Olsen et al. | Aug 2002 | B1 |
6436030 | Rehil | Aug 2002 | B2 |
6440167 | Shimizu | Aug 2002 | B2 |
6443964 | Ory et al. | Sep 2002 | B1 |
6447551 | Goldmann | Sep 2002 | B1 |
6447802 | Sessions et al. | Sep 2002 | B2 |
6448378 | Devore et al. | Sep 2002 | B2 |
6451032 | Ory et al. | Sep 2002 | B1 |
6451301 | Sessions et al. | Sep 2002 | B1 |
6454787 | Maddalo et al. | Sep 2002 | B1 |
6458889 | Trollsas et al. | Oct 2002 | B1 |
6477865 | Matsumoto | Nov 2002 | B1 |
6479072 | Morgan et al. | Nov 2002 | B1 |
6485503 | Jacobs et al. | Nov 2002 | B2 |
6500464 | Ceres et al. | Dec 2002 | B2 |
6500777 | Wiseman et al. | Dec 2002 | B1 |
6509031 | Miller et al. | Jan 2003 | B1 |
6511958 | Atkinson et al. | Jan 2003 | B1 |
6514286 | Leatherbury et al. | Feb 2003 | B1 |
6514514 | Atkinson et al. | Feb 2003 | B1 |
6540773 | Dong | Apr 2003 | B2 |
6541023 | Andre et al. | Apr 2003 | B1 |
6548077 | Gunasekaran | Apr 2003 | B1 |
6554855 | Dong | Apr 2003 | B1 |
6559119 | Burgess et al. | May 2003 | B1 |
6566345 | Miller et al. | May 2003 | B2 |
6575988 | Rousseau | Jun 2003 | B2 |
6576019 | Atala | Jun 2003 | B1 |
6596002 | Therin et al. | Jul 2003 | B2 |
6596304 | Bayon et al. | Jul 2003 | B1 |
6599323 | Melican et al. | Jul 2003 | B2 |
6599524 | Li et al. | Jul 2003 | B2 |
6599690 | Abraham et al. | Jul 2003 | B1 |
6610006 | Amid et al. | Aug 2003 | B1 |
6613348 | Jain | Sep 2003 | B1 |
6616685 | Rousseau | Sep 2003 | B2 |
6623963 | Mueller et al. | Sep 2003 | B1 |
6630414 | Matsumoto | Oct 2003 | B1 |
6637437 | Hungerford et al. | Oct 2003 | B1 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6645226 | Jacobs et al. | Nov 2003 | B1 |
6652594 | Francis et al. | Nov 2003 | B2 |
6652595 | Nicolo | Nov 2003 | B1 |
6653450 | Berg et al. | Nov 2003 | B1 |
6656206 | Corcoran et al. | Dec 2003 | B2 |
6660280 | Allard et al. | Dec 2003 | B1 |
6669735 | Pelissier | Dec 2003 | B1 |
6670018 | Fujita et al. | Dec 2003 | B2 |
6682760 | Noff et al. | Jan 2004 | B2 |
6685714 | Rousseau | Feb 2004 | B2 |
6706684 | Bayon et al. | Mar 2004 | B1 |
6706690 | Reich et al. | Mar 2004 | B2 |
6712859 | Rousseau et al. | Mar 2004 | B2 |
6719795 | Bryan et al. | Apr 2004 | B1 |
6723335 | Moehlenbruck et al. | Apr 2004 | B1 |
6726660 | Hessel et al. | Apr 2004 | B2 |
6730299 | Tayot et al. | May 2004 | B1 |
6736823 | Darois et al. | May 2004 | B2 |
6736854 | Vadurro et al. | May 2004 | B2 |
6737371 | Planck et al. | May 2004 | B1 |
6743435 | Devore et al. | Jun 2004 | B2 |
6746458 | Cloud | Jun 2004 | B1 |
6752834 | Geistlich et al. | Jun 2004 | B2 |
6755868 | Rousseau | Jun 2004 | B2 |
6773723 | Spiro et al. | Aug 2004 | B1 |
6783554 | Amara et al. | Aug 2004 | B2 |
6790213 | Cherok et al. | Sep 2004 | B2 |
6790454 | Abdul et al. | Sep 2004 | B1 |
6800082 | Rousseau | Oct 2004 | B2 |
6833408 | Sehl et al. | Dec 2004 | B2 |
6835336 | Watt | Dec 2004 | B2 |
6852330 | Bowman et al. | Feb 2005 | B2 |
6869938 | Schwartz et al. | Mar 2005 | B1 |
6872227 | Sump et al. | Mar 2005 | B2 |
6893653 | Abraham et al. | May 2005 | B2 |
6896904 | Spiro et al. | May 2005 | B2 |
6926723 | Mulhauser et al. | Aug 2005 | B1 |
6936276 | Spiro et al. | Aug 2005 | B2 |
6939562 | Spiro et al. | Sep 2005 | B2 |
6949625 | Tayot | Sep 2005 | B2 |
6966918 | Schuldt-Hempe et al. | Nov 2005 | B1 |
6971252 | Therin et al. | Dec 2005 | B2 |
6974679 | Andre et al. | Dec 2005 | B2 |
6974862 | Ringeisen et al. | Dec 2005 | B2 |
6977231 | Matsuda | Dec 2005 | B1 |
6984392 | Bechert et al. | Jan 2006 | B2 |
6988386 | Okawa et al. | Jan 2006 | B1 |
7011688 | Gryska et al. | Mar 2006 | B2 |
7021086 | Ory et al. | Apr 2006 | B2 |
7022358 | Eckmayer et al. | Apr 2006 | B2 |
7025063 | Snitkin et al. | Apr 2006 | B2 |
7041868 | Greene et al. | May 2006 | B2 |
7060103 | Carr et al. | Jun 2006 | B2 |
RE39172 | Bayon et al. | Jul 2006 | E |
7070558 | Gellman et al. | Jul 2006 | B2 |
7087065 | Ulmsten et al. | Aug 2006 | B2 |
7094261 | Zotti et al. | Aug 2006 | B2 |
7098315 | Schaufler | Aug 2006 | B2 |
7101381 | Ford et al. | Sep 2006 | B2 |
7115220 | Dubson et al. | Oct 2006 | B2 |
7156804 | Nicolo | Jan 2007 | B2 |
7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
7175852 | Simmoteit et al. | Feb 2007 | B2 |
7192604 | Brown et al. | Mar 2007 | B2 |
7207962 | Anand et al. | Apr 2007 | B2 |
7214765 | Ringeisen et al. | May 2007 | B2 |
7226611 | Yura et al. | Jun 2007 | B2 |
7229453 | Anderson et al. | Jun 2007 | B2 |
7252837 | Guo et al. | Aug 2007 | B2 |
7279177 | Looney et al. | Oct 2007 | B2 |
7331199 | Ory et al. | Feb 2008 | B2 |
7393319 | Merade et al. | Jul 2008 | B2 |
7556598 | Rao | Jul 2009 | B2 |
7594921 | Browning | Sep 2009 | B2 |
7614258 | Cherok et al. | Nov 2009 | B2 |
7615065 | Priewe et al. | Nov 2009 | B2 |
7662169 | Wittmann | Feb 2010 | B2 |
7670380 | Cauthen, III et al. | Mar 2010 | B2 |
7682381 | Rakos et al. | Mar 2010 | B2 |
7709017 | Tayot et al. | May 2010 | B2 |
7718556 | Matsuda et al. | May 2010 | B2 |
7732354 | Fricke et al. | Jun 2010 | B2 |
7785334 | Ford et al. | Aug 2010 | B2 |
7789888 | Bartee et al. | Sep 2010 | B2 |
7799767 | Lamberti et al. | Sep 2010 | B2 |
7806905 | Ford et al. | Oct 2010 | B2 |
7824420 | Eldridge et al. | Nov 2010 | B2 |
7828854 | Rousseau et al. | Nov 2010 | B2 |
7900484 | Cherok et al. | Mar 2011 | B2 |
7931695 | Ringeisen | Apr 2011 | B2 |
8048441 | Craig et al. | Nov 2011 | B2 |
8052759 | Dupic et al. | Nov 2011 | B2 |
8079023 | Chen | Dec 2011 | B2 |
8100924 | Browning | Jan 2012 | B2 |
8123817 | Intoccia et al. | Feb 2012 | B2 |
8142515 | Therin et al. | Mar 2012 | B2 |
8157821 | Browning | Apr 2012 | B2 |
8157822 | Browning | Apr 2012 | B2 |
8182545 | Cherok et al. | May 2012 | B2 |
8197837 | Jamiolkowski et al. | Jun 2012 | B2 |
8206632 | Rousseau et al. | Jun 2012 | B2 |
8215310 | Browning | Jul 2012 | B2 |
8317872 | Adams | Nov 2012 | B2 |
8323675 | Greenawalt | Dec 2012 | B2 |
8343232 | Adzich et al. | Jan 2013 | B2 |
8366787 | Brown et al. | Feb 2013 | B2 |
8435307 | Paul | May 2013 | B2 |
8470355 | Skalla et al. | Jun 2013 | B2 |
8562633 | Cully et al. | Oct 2013 | B2 |
8574627 | Martakos et al. | Nov 2013 | B2 |
8709094 | Stad et al. | Apr 2014 | B2 |
8734471 | Deitch | May 2014 | B2 |
8753360 | Gleiman et al. | Jun 2014 | B2 |
8758800 | Stopek et al. | Jun 2014 | B2 |
8784294 | Goddard | Jul 2014 | B2 |
8814887 | Walther et al. | Aug 2014 | B2 |
8828092 | Toso et al. | Sep 2014 | B2 |
8834864 | Odar et al. | Sep 2014 | B2 |
8846060 | Archibald et al. | Sep 2014 | B2 |
8865215 | Ladet et al. | Oct 2014 | B2 |
8877233 | Obermiller et al. | Nov 2014 | B2 |
8911504 | Mathisen et al. | Dec 2014 | B2 |
8920370 | Sholev et al. | Dec 2014 | B2 |
8945663 | Pacetti | Feb 2015 | B2 |
8956373 | Ford et al. | Feb 2015 | B2 |
8962006 | Bayon et al. | Feb 2015 | B2 |
8968762 | Ladet et al. | Mar 2015 | B2 |
8979935 | Lozier et al. | Mar 2015 | B2 |
9034357 | Stopek | May 2015 | B2 |
9113993 | Lee | Aug 2015 | B2 |
9211175 | Stopek et al. | Dec 2015 | B2 |
9216075 | Bailly et al. | Dec 2015 | B2 |
9980802 | Bailly et al. | May 2018 | B2 |
20020077661 | Saadat | Jun 2002 | A1 |
20020087174 | Capello | Jul 2002 | A1 |
20020095218 | Carr et al. | Jul 2002 | A1 |
20030086975 | Ringeisen | May 2003 | A1 |
20030114937 | Leatherbury et al. | Jun 2003 | A1 |
20030133967 | Ruszczak et al. | Jul 2003 | A1 |
20030225355 | Butler | Dec 2003 | A1 |
20040019360 | Farnsworth et al. | Jan 2004 | A1 |
20040034373 | Schuldt-Hempe et al. | Feb 2004 | A1 |
20040054376 | Ory et al. | Mar 2004 | A1 |
20040059356 | Gingras | Mar 2004 | A1 |
20040101546 | Gorman et al. | May 2004 | A1 |
20050002893 | Goldmann | Jan 2005 | A1 |
20050021058 | Negro | Jan 2005 | A1 |
20050085924 | Darois et al. | Apr 2005 | A1 |
20050113849 | Popadiuk et al. | May 2005 | A1 |
20050137512 | Campbell et al. | Jun 2005 | A1 |
20050142161 | Freeman et al. | Jun 2005 | A1 |
20050148963 | Brennan | Jul 2005 | A1 |
20050175659 | Macomber et al. | Aug 2005 | A1 |
20050232979 | Shoshan | Oct 2005 | A1 |
20050267521 | Forsberg | Dec 2005 | A1 |
20050288691 | Leiboff | Dec 2005 | A1 |
20060064175 | Pelissier et al. | Mar 2006 | A1 |
20060116696 | Odermatt et al. | Jun 2006 | A1 |
20060135921 | Wiercinski et al. | Jun 2006 | A1 |
20060147501 | Hillas et al. | Jul 2006 | A1 |
20060195010 | Arnal et al. | Aug 2006 | A1 |
20060216320 | Kitazono et al. | Sep 2006 | A1 |
20060252981 | Matsuda et al. | Nov 2006 | A1 |
20060253203 | Alvarado | Nov 2006 | A1 |
20060282103 | Fricke et al. | Dec 2006 | A1 |
20070088391 | Mcalexander et al. | Apr 2007 | A1 |
20070129736 | Solecki | Jun 2007 | A1 |
20070198040 | Buevich et al. | Aug 2007 | A1 |
20070299538 | Roeber | Dec 2007 | A1 |
20080091276 | Deusch et al. | Apr 2008 | A1 |
20080109017 | Herweck et al. | May 2008 | A1 |
20080113001 | Herweck et al. | May 2008 | A1 |
20080147099 | Uen | Jun 2008 | A1 |
20080147200 | Rousseau et al. | Jun 2008 | A1 |
20080172071 | Barker | Jul 2008 | A1 |
20080255593 | St-Germain | Oct 2008 | A1 |
20090035341 | Wagener et al. | Feb 2009 | A1 |
20090036996 | Roeber | Feb 2009 | A1 |
20090068250 | Gravagna et al. | Mar 2009 | A1 |
20090105526 | Piroli et al. | Apr 2009 | A1 |
20090163936 | Yang et al. | Jun 2009 | A1 |
20090187197 | Roeber et al. | Jul 2009 | A1 |
20090192530 | Adzich et al. | Jul 2009 | A1 |
20090204129 | Fronio | Aug 2009 | A1 |
20090216338 | Gingras et al. | Aug 2009 | A1 |
20090270999 | Brown | Oct 2009 | A1 |
20090281558 | Li et al. | Nov 2009 | A1 |
20090318752 | Evans et al. | Dec 2009 | A1 |
20100104608 | Abuzaina et al. | Apr 2010 | A1 |
20100241145 | Cook | Sep 2010 | A1 |
20100318108 | Datta et al. | Dec 2010 | A1 |
20110015760 | Kullas | Jan 2011 | A1 |
20110144667 | Horton et al. | Jun 2011 | A1 |
20110178538 | Cook | Jul 2011 | A1 |
20110190795 | Hotter et al. | Aug 2011 | A1 |
20110236460 | Stopek et al. | Sep 2011 | A1 |
20110238094 | Thomas et al. | Sep 2011 | A1 |
20110251699 | Ladet et al. | Oct 2011 | A1 |
20110257666 | Ladet et al. | Oct 2011 | A1 |
20110266778 | Jakobsson | Nov 2011 | A1 |
20120016388 | Houard et al. | Jan 2012 | A1 |
20120029537 | Mortarino | Feb 2012 | A1 |
20120065727 | Reneker et al. | Mar 2012 | A1 |
20120082712 | Stopek et al. | Apr 2012 | A1 |
20120116425 | Intoccia et al. | May 2012 | A1 |
20120150204 | Mortarino et al. | Jun 2012 | A1 |
20120165937 | Montanari et al. | Jun 2012 | A1 |
20120179175 | Hammell et al. | Jul 2012 | A1 |
20120179176 | Wilson et al. | Jul 2012 | A1 |
20120197415 | Montanari et al. | Aug 2012 | A1 |
20140044861 | Boey et al. | Feb 2014 | A1 |
20140364684 | Lecuivre et al. | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
1317836 | May 1993 | CA |
101489502 | Jul 2009 | CN |
201879864 | Jun 2011 | CN |
19544162 | Apr 1997 | DE |
19718903 | Dec 1997 | DE |
19636961 | Mar 1998 | DE |
19751733 | Dec 1998 | DE |
19832634 | Jan 2000 | DE |
10019604 | Oct 2001 | DE |
10120942 | Oct 2001 | DE |
10043396 | Jun 2002 | DE |
0194192 | Sep 1986 | EP |
0248544 | Dec 1987 | EP |
0263360 | Apr 1988 | EP |
0276890 | Aug 1988 | EP |
0372969 | Jun 1990 | EP |
0531742 | Mar 1993 | EP |
0544485 | Jun 1993 | EP |
0552576 | Jul 1993 | EP |
0611561 | Aug 1994 | EP |
0614650 | Sep 1994 | EP |
0621014 | Oct 1994 | EP |
0625891 | Nov 1994 | EP |
0637452 | Feb 1995 | EP |
0664132 | Jul 1995 | EP |
0705878 | Apr 1996 | EP |
0719527 | Jul 1996 | EP |
0774240 | May 1997 | EP |
0797962 | Oct 1997 | EP |
0800791 | Oct 1997 | EP |
0827724 | Mar 1998 | EP |
0836838 | Apr 1998 | EP |
0847727 | Jun 1998 | EP |
0876808 | Nov 1998 | EP |
0895762 | Feb 1999 | EP |
0898944 | Mar 1999 | EP |
1017415 | Jul 2000 | EP |
1036545 | Sep 2000 | EP |
1052319 | Nov 2000 | EP |
1055757 | Nov 2000 | EP |
1090590 | Apr 2001 | EP |
1216717 | Jun 2002 | EP |
1216718 | Jun 2002 | EP |
0693523 | Nov 2002 | EP |
1273312 | Jan 2003 | EP |
1315468 | Jun 2003 | EP |
1382728 | Jan 2004 | EP |
1484070 | Dec 2004 | EP |
1561480 | Aug 2005 | EP |
1645232 | Apr 2006 | EP |
1674048 | Jun 2006 | EP |
1691606 | Aug 2006 | EP |
1782848 | May 2007 | EP |
2229918 | Sep 2010 | EP |
2244853 | Apr 1975 | FR |
2257262 | Aug 1975 | FR |
2308349 | Nov 1976 | FR |
2453231 | Oct 1980 | FR |
2612392 | Sep 1988 | FR |
2715309 | Jul 1995 | FR |
2715405 | Jul 1995 | FR |
2724563 | Mar 1996 | FR |
2730406 | Aug 1996 | FR |
2744906 | Aug 1997 | FR |
2766698 | Feb 1999 | FR |
2771622 | Jun 1999 | FR |
2773057 | Jul 1999 | FR |
2774277 | Aug 1999 | FR |
2779937 | Dec 1999 | FR |
2859624 | Dec 2005 | FR |
2876020 | Apr 2006 | FR |
2863277 | Jun 2006 | FR |
2884706 | Apr 2008 | FR |
2929834 | Oct 2009 | FR |
2951069 | Apr 2011 | FR |
2953709 | Jun 2011 | FR |
1174814 | Dec 1969 | GB |
2051153 | Jan 1981 | GB |
2306110 | Apr 1997 | GB |
H0332677 | Mar 1991 | JP |
H05237128 | Sep 1993 | JP |
H09137380 | May 1997 | JP |
H11146888 | Jun 1999 | JP |
2008538300 | Oct 2008 | JP |
2010508121 | Mar 2010 | JP |
2011078767 | Apr 2011 | JP |
8902445 | Mar 1989 | WO |
8908467 | Sep 1989 | WO |
9012551 | Nov 1990 | WO |
9206639 | Apr 1992 | WO |
9220349 | Nov 1992 | WO |
9307321 | Apr 1993 | WO |
9311805 | Jun 1993 | WO |
9318174 | Sep 1993 | WO |
9417747 | Aug 1994 | WO |
9507666 | Mar 1995 | WO |
9518638 | Jul 1995 | WO |
9532687 | Dec 1995 | WO |
9603091 | Feb 1996 | WO |
9608277 | Mar 1996 | WO |
9609795 | Apr 1996 | WO |
9614805 | May 1996 | WO |
9641588 | Dec 1996 | WO |
9735533 | Oct 1997 | WO |
9831345 | Jul 1998 | WO |
9835632 | Aug 1998 | WO |
9849967 | Nov 1998 | WO |
9905990 | Feb 1999 | WO |
9906079 | Feb 1999 | WO |
9906080 | Feb 1999 | WO |
9951163 | Oct 1999 | WO |
0016821 | Mar 2000 | WO |
0067663 | Nov 2000 | WO |
0115625 | Mar 2001 | WO |
0180773 | Nov 2001 | WO |
0181667 | Nov 2001 | WO |
0207648 | Jan 2002 | WO |
0217853 | Mar 2002 | WO |
02078568 | Oct 2002 | WO |
03002168 | Jan 2003 | WO |
2004004600 | Jan 2004 | WO |
2004071349 | Aug 2004 | WO |
2004078120 | Sep 2004 | WO |
2004103212 | Dec 2004 | WO |
2005011280 | Feb 2005 | WO |
2005013863 | Feb 2005 | WO |
2005018698 | Mar 2005 | WO |
2005048708 | Jun 2005 | WO |
2005105172 | Nov 2005 | WO |
2006018552 | Feb 2006 | WO |
2006023444 | Mar 2006 | WO |
2006040760 | Apr 2006 | WO |
2009071998 | Jun 2009 | WO |
2009031035 | Jan 2010 | WO |
2010043978 | Apr 2010 | WO |
2010043980 | Apr 2010 | WO |
2007048099 | Sep 2010 | WO |
2011007062 | Jan 2011 | WO |
2011026987 | Mar 2011 | WO |
2011038740 | Apr 2011 | WO |
Entry |
---|
“A Basic Explanation of Grain Lines,” Fabrics and Textiles, Patternmaking, Sewing and Construction; Feb. 11, 2011 (https://www.thecuttingclass.com/grainlines) (Year: 2011). |
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003. |
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4). |
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6). |
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1). |
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004. |
Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506. |
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25. |
Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany. |
Haneji, K et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009. |
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4). |
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5). |
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19. |
International Search Report issued in corresponding application No. PCT/EP2012/062672, dated Sep. 4, 2012. |
Japanese Office Action dated May 2, 2016 in corresponding Japanese Patent Application No. 2014-519494, together with English translation, 9 pages. |
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26. |
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle, ” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3). |
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165. |
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63. |
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7). |
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). |
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36. |
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10. |
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2). |
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136. |
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34. |
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007. |
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220, 18(2). |
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2. |
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299. |
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5. |
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215, 126(3). |
Number | Date | Country | |
---|---|---|---|
20210298887 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16927735 | Jul 2020 | US |
Child | 17343671 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15963523 | Apr 2018 | US |
Child | 16927735 | US | |
Parent | 14232378 | US | |
Child | 15963523 | US |